expand_moreexpand_less
Aeon
Al Jazeera
América Economía
Blitz
Buenos Aires Herald
Deutsche Welle
Dnevnik
E-International
Haaretz
Il Manifesto Global
Japan Today
Khaama PressMiddle East Monitor
New Eastern OutlookNikkei Asian ReviewOped Column
Pravda.sk
Project Syndicate
Psychology TodayRT.comSME.sk
South China Morning PostThe Asahi ShimbunThe DiplomatThe Japan NewsThe Japan Times
The Korea TimesThe Times of IsraelThe Times of Israel (Blogs)Večer
العين الإخبارية 
Toi StaffEmanuel FabianJacob MagidAgenciesReuters
Gideon LevyDavid HorovitzThe Japan News EditorialLazar BermanLuke TressGianluca PacchianiAmérica EconomíaRon KampeasCathryn J. PrinceOthman Moqbel
Belen Fernandez
Andrew MitrovicaThe Asahi ShimbunJeremy SharonSam SokolRenee Ghert-ZandCharlie SummersBradley BlankenshipAmanda Borschel-DanElana KirshAmira HassCarolina LandsmannSue Surkes
Mort LaitnerZvi Bar&x27ElAmy SpiroNatan OdenheimerYuli TamirStephen GrovesEran Yashiv
Rami G Khouri
Ali Fathollah-NejadSlavoj ŽižekCanaan LidorRachel MarsdenNoa LandauEfrat Rayten
Nikkei EditorialWilliam Noah GlucroftShalom YerushalmiAbbas JumaJames ShimanyulaMegan KangJapan TodayE-International Relations
|
|
Bruce GilQuartz |
Amgen stock picked up 13% during Friday morning trading, a day after its CEO Robert Bradway teased encouraging trial results of its experimental...
Novo Nordisk responded this week to the Federal Trade Commission’s (FTC) suggestion that it filed ‘junk’ patents to prevent competition and...
Sony Pictures and Apollo Global Management have made a $26 billion all-cash offer to buy Paramount Global, the parent company of CBS, MTV, and...
Novo Nordisk responded today to the U.S. Federal Trade Commission’s (FTC) suggestion that it filed ‘junk’ patents to prevent competition and...
Novo Nordisk raised today both its full year sales and operational profit guidance for the year after reporting booming sales of its blockbuster...
The skyrocketing popularity of the diabetes drug Ozempic has put a heavy burden on public spending in Denmark, the home country of the drug’s...
Johnson & Johnson announced Wednesday that it plans to pay nearly $6.5 billion over 25 years to settle all pending and future U.S. lawsuits alleging...
Novo Nordisk, the maker of the mega-popular diabetes and weight loss medications Ozempic and Wegovy, is set to report its first quarter earnings on...
The U.S. Federal Trade Commission (FDA) announced on Tuesday that it is disputing over 300 patent listings across 20 different brand name drugs in an...
Eli Lilly stock jumped 5% during Tuesday morning trading to about $773 a share after the pharma giant reported better-than-expected sales of its...
Walmart announced today that it is closing all 51 of its health centers across five states and its virtual health care service due to a lack of...
Paramount Global, the parent company of CBS and MTV, announced late Monday that CEO Bob Bakish is stepping down from his role. Read more...
A dose of Wegovy’s highly-coveted weight loss drug is no longer in limited supply, according to Food and Drug Administration (FDA) drug shortage...
Philips stock soared nearly 30% on Monday to over $27 after the the Dutch medical device maker announced it has agreed to pay $1.1 billion to resolve...
Paramount Global CEO Bob Bakish could be let go from the company as soon as today, according to various news outlets. Read more...
You may think that a class of drugs that has been shown to help users lose 15% to 20% of their body weight may put the fitness industry on edge. But...
The U.S. Food and Drug Administration (FDA) said on Thursday that genetic fragments of the H5N1 bird flu virus have been detected in one in five...
AbbVie raised its full year profit guidance today, even as sales of its flagship medication have continued to fall. Read more...
A new report from Morgan Stanley finds that people using GLP-1 drugs — among them Ozempic, Wegovy, Mounjaro, and Zepbound — reduce their...
Pharma giants Merck and Bristol-Myers Squibb are both getting ready for some of their key drug patents to expire in the next few years. Both companies...
It has been a busy week for pharma giants reporting their latest quarterly earnings and a lot of them have exceeded analysts’ estimates. Read...
Merck’s stock jumped 3% to about $130 during Thursday morning trading after the New Jersey-based pharmaceutical company reported higher than...
U.S. Sen. Bernie Sanders sent letter on Wednesday to Novo Nordisk CEO Lars Fruergaard Jørgensen announcing that the Senate Committee on Health,...
What is “the algorithm?” Read more...
Biogen stock jumped 5% to about $202 during Wednesday morning trading, after the Cambridge, Massachusetts-based pharmaceutical company reported higher...
Millions of Americans could now be eligible for Medicare to cover their prescriptions of the popular weight loss drug Wegovy, according to a new...
It’s not only food CEOs who need to worry about their bottom lines thanks to in-demand weight loss drugs like Ozempic. Big Tobacco and Alcohol have...
UnitedHealth Group, the parent company of the largest health insurer in the U.S., confirmed this week that it paid a ransom in relation to a...
Over half of people who are on Ozempic or another GLP-1 drug — a class of weight loss and diabetes medications— say they are spending less money...
The median price for U.S. luxury homes rose 9% year over year to a record $1.225 million in the first quarter of 2024, according to a new report from...
UBS Global Research downgraded its rating of what it calls the “Big Six” tech stocks—Apple, Amazon, Google-parent Alphabet, Meta, Microsoft and...
DNB Asset Management reduced its stakes in Magnificent Seven members Apple, Microsoft, and Tesla in the first three months of 2024, a filing with the...
Despite Hollywood often being at a standstill for half the year in 2023 due to two strikes, Warner Bros. Discovery CEO David Zaslav saw his take-home...
The U.S. Federal Aviation Administration said on Friday that it is increasing the amount of required rest time that air traffic controllers get...
Shares of consumer goods giant Procter & Gamble (P&G) slipped during Friday morning trading, after price hikes on certain products kept the company...
The Food and Drug Administration said this week that more doses of Eli Lilly’s popular diabetes and weight loss drugs will be in limited supply...
The World Health Organization (WHO) this month launched what it is calling a Smart AI Resource Assistant for Health, or Sarah for short. However the...
It took over a hundred scientists from around the world two years to finally get on the same pageregarding the best language to use when talking about...
Eli Lilly, the world’s most valuable pharmaceutical company, can’t keep up with soaring demand of its popular diabetes and weight loss drugs. Read...
Eli Lilly announced today that the drug behind Zepbound was found to help alleviate sleep apnea in patients with obesity in late-stage clinical...
Catalog errors on Amazon’s video streaming service are so bad that they’ve kept some viewers from finishing shows on the platform, according to ...
Johnson & Johnson’s recent investments in medical devices helped boost sales, but the company’s total revenue in the first quarter of the year...
UnitedHealth Group, the largest health insurance company in the U.S., was the top performer in S&P 500 Tuesday morning after it reported higher-than...
BrandShield, a cybersecurity firm that detects trademark infringement and counterfeit sales online, said on Monday that it shut down more than 250...
Berkshire Hathaway, the holdings company founded and led by renowned investor Warren Buffett, bought 1.9 million shares Liberty Sirius XM last week...
The activist hedge fund Shah Capital blasted the leadership of Novavax for not leveraging concerns some people have about mRNA vaccines to boost sales...
Roku, the maker of SmartTV and streaming devices, said Friday that about 576,000 user accounts were compromised in the second cyberattack to hit the...
BlackRock CEO Larry Fink said on Friday that he expects the Federal Reserve to cut interest rates at least twice this year even if inflation stays...
A European Union regulator found no evidence of a “causal” link between GLP-1 drugs — such as Ozempic and Wegovy — and suicidal thoughts.Read...
Moderna stock rose after new data suggested that its experimental vaccine could be used to treat a variety of cancers. The American Society of...
login
who are we?
contact us
qosheapp
